Reviews
Summary
Positives
- Patients in the RECOVER-NEURO project (n=378 across 22 sites) commonly see no measurable benefit from tDCS combined with BrainHQ cognitive training over 10 weeks — active treatments commonly fail to outperform controls on any of the 12+ outcome measures Reddit.
Negatives
- Long COVID patients on tDCS combined with cognitive training in the NIH RECOVER-NEURO cohort saw no measurable benefit over sham — the primary cognitive endpoint showed an adjusted mean difference of 0.0, and all groups improved similarly JAMA.
- Patient analyses describe RECOVER-NEURO as a flop for cognitive Long COVID, with cognitive training, structured rehabilitation, and tDCS all failing to outperform controls — skin irritation and tingling were among reported side effects in the active arm Health Rising.
Hurdles & Side Effects
- A separate Brazilian clinical trial (NCT06074848) is specifically investigating tDCS for management of post-COVID disorders, suggesting ongoing research interest despite the RECOVER-NEURO results Reddit.
Was this summary accurate?
Tell us how this treatment affected you
Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision.
Find care
Get Transcranial Direct Current Stimulation (tDCS)
Providers
0 matches
No linked providers yet.
Pharmacies
0 matches
No linked pharmacies yet.